Skip to main content
Top
Published in: European Radiology 2/2024

23-08-2023 | Magnetic Resonance Imaging | Magnetic Resonance

Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma

Authors: Mei Ling Xiao, Le Fu, Yan Wei, Ai E Liu, Jie Jun Cheng, Feng Hua Ma, Hai Ming Li, Yong Ai Li, Zi Jing Lin, Guo Fu Zhang, Jin Wei Qiang

Published in: European Radiology | Issue 2/2024

Login to get access

Abstract

Objective

To develop a comprehensive nomogram based on MRI intra- and peritumoral radiomics signatures and independent risk factors for predicting parametrial invasion (PMI) in patients with early-stage cervical adenocarcinoma (AC) and adenosquamous carcinoma (ASC).

Methods

A total of 460 patients with IB to IIB cervical AC and ASC who underwent preoperative MRI examination and radical trachelectomy/hysterectomy were retrospectively enrolled and divided into primary, internal validation, and external validation cohorts. The original (Ori) and wavelet (Wav)-transform features were extracted from the volumetric region of interest of the tumour (ROI-T) and 3mm- and 5mm-peritumoral rings (ROI-3 and ROI-5), respectively. Then the Ori and Ori-Wav feature-based radiomics signatures from the tumour (RST) and 3 mm- and 5 mm-peritumoral regions (RS3 and RS5) were independently built and their diagnostic performances were compared to select the optimal ones. Finally, the nomogram was developed by integrating optimal intra- and peritumoral signatures and clinical independent risk factors based on multivariable logistic regression analysis.

Results

FIGO stage, disruption of the cervical stromal ring on MRI (DCSRMR), parametrial invasion on MRI (PMIMR), and serum CA-125 were identified as independent risk factors. The nomogram constructed by integrating independent risk factors, Ori-Wav feature-based RST, and RS5 yielded AUCs of 0.874 (0.810–0.922), 0.885 (0.834–0.924), and 0.966 (0.887–0.995) for predicting PMI in the primary, internal and external validation cohorts, respectively. Furthermore, the nomogram was superior to radiomics signatures and clinical model for predicting PMI in three cohorts.

Conclusion

The nomogram can preoperatively, accurately, and noninvasively predict PMI in patients with early-stage cervical AC and ASC.

Clinical relevance statement

The nomogram can preoperatively, accurately, and noninvasively predict PMI and facilitate precise treatment decisions regarding chemoradiotherapy or radical hysterectomy in patients with early-stage cervical AC and ASC.

Key Points

  • The accurate preoperative prediction of PMI in early-stage cervical AC and ASC can facilitate precise treatment decisions regarding chemoradiotherapy or radical hysterectomy.
  • The nomogram integrating independent risk factors, Ori-Wav feature-based RST, and RS5 can preoperatively, accurately, and noninvasively predict PMI in early-stage cervical AC and ASC.
  • The nomogram was superior to radiomics signatures and clinical model for predicting PMI in early-stage cervical AC and ASC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed
2.
go back to reference Zhang X, Lv Z, Xu X, Yin Z, Lou H (2020) Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery. BMC Cancer 20(1):664CrossRefPubMedPubMedCentral Zhang X, Lv Z, Xu X, Yin Z, Lou H (2020) Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery. BMC Cancer 20(1):664CrossRefPubMedPubMedCentral
3.
go back to reference Yokoi E, Mabuchi S, Takahashi R et al (2017) Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. J Gynecol Oncol 28(2):e19CrossRefPubMed Yokoi E, Mabuchi S, Takahashi R et al (2017) Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. J Gynecol Oncol 28(2):e19CrossRefPubMed
4.
go back to reference Cao L, Wen H, Feng Z, Han X, Wu X (2019) Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer. Int J Gynecol Cancer 29(8):1244–1251CrossRefPubMed Cao L, Wen H, Feng Z, Han X, Wu X (2019) Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer. Int J Gynecol Cancer 29(8):1244–1251CrossRefPubMed
5.
go back to reference Roma AA, Mistretta TA, Diaz De Vivar A et al (2016) New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol 141(1):36–42CrossRefPubMedPubMedCentral Roma AA, Mistretta TA, Diaz De Vivar A et al (2016) New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol 141(1):36–42CrossRefPubMedPubMedCentral
6.
go back to reference Kong TW, Kim J, Son JH et al (2016) Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy. Gynecol Oncol 142(1):109–114CrossRefPubMed Kong TW, Kim J, Son JH et al (2016) Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy. Gynecol Oncol 142(1):109–114CrossRefPubMed
7.
go back to reference Wright JD, Grigsby PW, Brooks R et al (2007) Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer 110(6):1281–1286CrossRefPubMed Wright JD, Grigsby PW, Brooks R et al (2007) Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer 110(6):1281–1286CrossRefPubMed
8.
go back to reference Frumovitz M, Sun CC, Schmeler KM et al (2009) Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol 114(1):93–99CrossRefPubMed Frumovitz M, Sun CC, Schmeler KM et al (2009) Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol 114(1):93–99CrossRefPubMed
9.
go back to reference Chang SJ, Bristow RE, Ryu HS (2012) A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer. Gynecol Oncol 126(1):82–86CrossRefPubMed Chang SJ, Bristow RE, Ryu HS (2012) A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer. Gynecol Oncol 126(1):82–86CrossRefPubMed
10.
go back to reference Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH (2013) Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer. J Surg Oncol 108(1):63–69CrossRefPubMed Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH (2013) Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer. J Surg Oncol 108(1):63–69CrossRefPubMed
11.
go back to reference Xiao ML, Wei Y, Zhang J et al (2022) MRI texture analysis for preoperative prediction of lymph node metastasis in patients with nonsquamous cell cervical carcinoma. Acad Radiol 29(11):1661–1671CrossRefPubMed Xiao ML, Wei Y, Zhang J et al (2022) MRI texture analysis for preoperative prediction of lymph node metastasis in patients with nonsquamous cell cervical carcinoma. Acad Radiol 29(11):1661–1671CrossRefPubMed
12.
go back to reference Dong D, Tang L, Li ZY et al (2019) Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 30(3):431–438CrossRefPubMedPubMedCentral Dong D, Tang L, Li ZY et al (2019) Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 30(3):431–438CrossRefPubMedPubMedCentral
13.
go back to reference Huang YQ, Liang CH, He L et al (2011) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 34(18):2157–2164CrossRef Huang YQ, Liang CH, He L et al (2011) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 34(18):2157–2164CrossRef
14.
go back to reference Wang T, Gao T, Guo H et al (2020) Preoperative prediction of parametrial invasion in early-stage cervical cancer with MRI-based radiomics nomogram. Eur Radiol 30(6):3585–3593CrossRefPubMed Wang T, Gao T, Guo H et al (2020) Preoperative prediction of parametrial invasion in early-stage cervical cancer with MRI-based radiomics nomogram. Eur Radiol 30(6):3585–3593CrossRefPubMed
15.
go back to reference Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266(3):717–740CrossRefPubMed Sala E, Rockall AG, Freeman SJ, Mitchell DG, Reinhold C (2013) The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. Radiology 266(3):717–740CrossRefPubMed
16.
go back to reference Raithatha A, Papadopoulou I, Stewart V, Barwick TD, Rockall AG, Bharwani N (2016) Cervical Cancer Staging: A Resident's Primer: Women's Imaging. Radiographics 36(3):933–934CrossRefPubMed Raithatha A, Papadopoulou I, Stewart V, Barwick TD, Rockall AG, Bharwani N (2016) Cervical Cancer Staging: A Resident's Primer: Women's Imaging. Radiographics 36(3):933–934CrossRefPubMed
17.
go back to reference Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C (2003) Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180(6):1621–1631CrossRefPubMed Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C (2003) Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol 180(6):1621–1631CrossRefPubMed
18.
go back to reference Sahdev A, Sohaib SA, Wenaden AE, Shepherd JH, Reznek RH (2007) The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer 17(3):629–636CrossRefPubMed Sahdev A, Sohaib SA, Wenaden AE, Shepherd JH, Reznek RH (2007) The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience. Int J Gynecol Cancer 17(3):629–636CrossRefPubMed
19.
go back to reference Zhang W, Zhang J, Yang J et al (2014) The role of magnetic resonance imaging in pretreatment evaluation of early-stage cervical cancer. Int J Gynecol Cancer 24(7):1292–1298CrossRefPubMed Zhang W, Zhang J, Yang J et al (2014) The role of magnetic resonance imaging in pretreatment evaluation of early-stage cervical cancer. Int J Gynecol Cancer 24(7):1292–1298CrossRefPubMed
20.
go back to reference Kato T, Takashima A, Kasamatsu T et al (2015) Gynecologic oncology study group of the japan clinical oncology group. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). Gynecol Oncol 137(1):34–39CrossRefPubMed Kato T, Takashima A, Kasamatsu T et al (2015) Gynecologic oncology study group of the japan clinical oncology group. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). Gynecol Oncol 137(1):34–39CrossRefPubMed
21.
go back to reference Kamimori T, Sakamoto K, Fujiwara K et al (2011) Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumour diameter in preoperative magnetic resonance imaging. Int J Gynecol Cancer 21(2):349–354CrossRefPubMed Kamimori T, Sakamoto K, Fujiwara K et al (2011) Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumour diameter in preoperative magnetic resonance imaging. Int J Gynecol Cancer 21(2):349–354CrossRefPubMed
22.
go back to reference Yamazaki H, Todo Y, Okamoto K, Yamashiro K, Kato H (2015) Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer. J Gynecol Oncol 26(4):255–261CrossRefPubMedPubMedCentral Yamazaki H, Todo Y, Okamoto K, Yamashiro K, Kato H (2015) Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer. J Gynecol Oncol 26(4):255–261CrossRefPubMedPubMedCentral
Metadata
Title
Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma
Authors
Mei Ling Xiao
Le Fu
Yan Wei
Ai E Liu
Jie Jun Cheng
Feng Hua Ma
Hai Ming Li
Yong Ai Li
Zi Jing Lin
Guo Fu Zhang
Jin Wei Qiang
Publication date
23-08-2023
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 2/2024
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10042-2

Other articles of this Issue 2/2024

European Radiology 2/2024 Go to the issue